XML 77 R17.htm IDEA: XBRL DOCUMENT
v3.21.2

DERIVATIVE FINANCIAL INSTRUMENTS | 12 Months Ended
--- | ---
Jul. 03, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
DERIVATIVE FINANCIAL INSTRUMENTS | DERIVATIVE FINANCIAL INSTRUMENTS As of July 3, 2021, the Company had outstanding foreign currency forward contracts with a total notional amount of $10.6 million. The maturity dates for these contracts and swaps extend through December 2021. As of July 3, 2021, the net amount of unrealized gain expected to be reclassified into earnings within the next 12 months is approximately $2.8 million. During the fiscal year ended July 3, 2021, the Company did not enter into any foreign currency forward contracts and settled $26.1 million of such contracts. During the fiscal year ended June 27, 2020, the Company entered into $23.8 million of foreign currency forward contracts and settled $26.7 million of such contracts. During the fiscal year ended June 29, 2019, the Company entered into $19.2 million of foreign currency forward contracts and settled $25.9 million of such contracts. Subsequent to July 3, 2021, the Company entered into $13.9 million of additional foreign currency forward contracts that extended our hedge position through June 2022. As of July 3, 2021, the aggregate notional amount of the Company’s outstanding foreign currency contracts along with their unrealized gains (losses) are expected to mature as summarized below (in thousands):
Quarter Ending |  | Notional Contracts and Swaps in MXN |  | Notional Contracts and Swaps in USD |  | Estimated Fair Value
October 2, 2021 |  | $ | 146,373 |  |  | $ | 5,502 |  |  | $ | 1,874 |
January 1, 2022 |  | $ | 137,973 |  |  | $ | 5,129 |  |  | $ | 1,740 |
On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of September 30, 2022, related to the borrowings outstanding under the term loan with Wells Fargo Bank. This interest rate swap contract was terminated on August 14, 2020 when the Company entered into a loan and security agreement with Bank of America. At date of termination this interest rate swap was in a liability position of $148,400, which will be amortized to interest expense over the original term of the swap. On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of November 1, 2023, related to the borrowings outstanding under the line of credit with Wells Fargo Bank. This interest rate swap contract was terminated on August 14, 2020 when the Company entered into a loan and security agreement with Bank of America. At date of termination this interest rate swap was in a liability position of $776,500, which will be amortized to interest expense over the original term of the swap. The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheets as of July 3, 2021 and June 27, 2020 (in thousands):
|  |  |  | July 3, 2021 |  | June 27, 2020
Derivatives Designated as Hedging Instruments |  | Balance Sheet Location |  | Fair Value |  | Fair Value
Foreign currency forward contracts & swaps |  | Other current assets |  | $ | 3,614 |  |  | $ | — |
Foreign currency forward contracts & swaps |  | Other long-term assets |  | $ | — |  |  | $ | 1,097 |
Foreign currency forward contracts & swaps |  | Other current liabilities |  | $ | — |  |  | $ | (1,960) |
Foreign currency forward contracts & swaps |  | Other long-term liabilities |  | $ | — |  |  | $ | (17) |
Interest rate swaps |  | Other current liabilities |  | $ | — |  |  | $ | (347) |
Interest rate swaps |  | Other long-term liabilities |  | $ | — |  |  | $ | (610) |
The following table summarizes the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the fiscal year 2021 (in thousands):
Derivatives Designated as Hedging Instruments | Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |  | AOCI Balance as of June 27, 2020 |  | Effective Portion Recorded In AOCI |  | Effective Portion Reclassified From AOCI Into Income |  | AOCI Balance as of July 3, 2021
Forward contracts | Cost of sales |  | $ | (759) |  |  | $ | 4,621 |  |  | $ | (1,141) |  |  | $ | 2,721 |
Interest rate swap | Interest expense |  | (741) |  |  | (223) |  |  | 315 |  |  | (649) |
Total |  |  | $ | (1,500) |  |  | $ | 4,398 |  |  | $ | (826) |  |  | $ | 2,072 |
The following table summarizes the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the fiscal year 2020 (in thousands):
Derivatives Designated as Hedging Instruments | Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |  | AOCI Balance as of June 29, 2019 |  | Effective Portion Recorded In AOCI |  | Effective Portion Reclassified From AOCI Into Income |  | AOCI Balance as of June 27, 2020
Forward contracts | Cost of sales |  | $ | 2,424 |  |  | $ | (865) |  |  | $ | (2,318) |  |  | $ | (759) |
Interest rate swap | Interest expense |  | 2 |  |  | (782) |  |  | 39 |  |  | (741) |
Total |  |  | $ | 2,426 |  |  | $ | (1,647) |  |  | $ | (2,279) |  |  | $ | (1,500) |
The following table summarizes the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the fiscal year 2019 (in thousands):
Derivatives Designated as Hedging Instruments | Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |  | AOCI Balance as of June 30, 2018 |  | Effective Portion Recorded In AOCI |  | Effective Portion Reclassified From AOCI Into Income |  | AOCI Balance as of June 29, 2019
Forward contracts & swaps | Cost of sales |  | $ | (988) |  |  | $ | 3,332 |  |  | $ | 80 |  |  | $ | 2,424 |
Interest rate swap | Interest expense |  | 19 |  |  | 2 |  |  | (19) |  |  | 2 |
Total |  |  | $ | (969) |  |  | $ | 3,334 |  |  | $ | 61 |  |  | $ | 2,426 |
As of July 3, 2021, the Company does not have any foreign exchange contracts with credit-risk-related contingent features. The Company is subject to the risk of fluctuating interest rates from our line of credit and foreign currency risk resulting from our China operations. The Company does not currently manage these risk exposures by using derivative instruments.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration